RLMD · Company research
Relmada Therapeutics, Inc. Common Stock (RLMD): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Relmada Therapeutics (RLMD) Rallies 6.94% to $3.39 as Buyers Test Upper Range - Volume Gap - https://www.siam.in/ | Relmada Therapeutics (RLMD) Rallies 6.94% to $3.39 as Buyers Test Upper Range - Volume Gap https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Oct 10, 2026 | neutral | 0 | 0.6 |
| RLMD Jumps As Relmada Insider Buying Sparks Bullish Focus - Timothy Sykes | RLMD Jumps As Relmada Insider Buying Sparks Bullish Focus Timothy Sykes | View source ↗ | Timothy Sykes | Sep 12, 2026 | neutral | 0 | 0.6 |
| Relmada (NASDAQ: RLMD) CEO buys stock in two open-market trades - Stock Titan | Relmada (NASDAQ: RLMD) CEO buys stock in two open-market trades Stock Titan | View source ↗ | Stock Titan | Sep 11, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: Chief Financial Officer of $RLMD Buys 120,200 Shares - Moomoo | Insider Purchase: Chief Financial Officer of $RLMD Buys 120,200 Shares Moomoo | View source ↗ | Moomoo | Sep 11, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: Chief Financial Officer of $RLMD Buys 120,200 Shares - Quiver Quantitative | Insider Purchase: Chief Financial Officer of $RLMD Buys 120,200 Shares Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 11, 2026 | neutral | 0 | 0.6 |
| Here's Why Relmada Therapeutics (RLMD) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance | Here's Why Relmada Therapeutics (RLMD) Is a Great 'Buy the Bottom' Stock Now Yahoo Finance | View source ↗ | Yahoo Finance | Aug 25, 2026 | neutral | 0 | 0.6 |
| Down 29.6% in 4 Weeks, Here's Why Relmada Therapeutics (RLMD) Looks Ripe for a Turnaround - Yahoo Finance | Down 29.6% in 4 Weeks, Here's Why Relmada Therapeutics (RLMD) Looks Ripe for a Turnaround Yahoo Finance | View source ↗ | Yahoo Finance | Aug 11, 2026 | neutral | 0 | 0.6 |
| Relmada Reports Q2 Loss As Cash Balance Reaches $217.7 Million - Quiver Quantitative | Relmada Reports Q2 Loss As Cash Balance Reaches $217.7 Million Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 6, 2026 | neutral | 0 | 0.6 |
| RLMD Forecast — Price Target — Prediction for 2027 - TradingView | RLMD Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| Relmada: NDV-01 Entering Phase 3 In NMIBC, But There's No Rush To Buy Stock Today - Seeking Alpha | Relmada: NDV-01 Entering Phase 3 In NMIBC, But There's No Rush To Buy Stock Today Seeking Alpha | View source ↗ | Seeking Alpha | Jun 19, 2026 | neutral | 0 | 0.6 |
| Relmada Therapeutics (RLMD): 10 Best Growth Stocks Under $30 to Buy Now - Yahoo Finance | Relmada Therapeutics (RLMD): 10 Best Growth Stocks Under $30 to Buy Now Yahoo Finance | View source ↗ | Yahoo Finance | Jun 19, 2026 | neutral | 0 | 0.6 |
| Why Is RLMD Stock Surging Premarket? NDV-01 Trial Update and $160M PIPE Deal - Tokenist | Why Is RLMD Stock Surging Premarket? NDV-01 Trial Update and $160M PIPE Deal Tokenist | View source ↗ | Tokenist | Mar 9, 2026 | neutral | 0 | 0.6 |
| RLMD Stock Soars Pre-Market: Phase 2 Bladder Cancer Trial Data Impresses Investors - Stocktwits | RLMD Stock Soars Pre-Market: Phase 2 Bladder Cancer Trial Data Impresses Investors Stocktwits | View source ↗ | Stocktwits | Mar 9, 2026 | neutral | 0 | 0.6 |
| Relmada Therapeutics, Inc. Common Stock (RLMD) Stock Price: Oct 8 Close $3.17 - Gotrade | Relmada Therapeutics, Inc. Common Stock (RLMD) Stock Price: Oct 8 Close $3.17 Gotrade | View source ↗ | Gotrade | Feb 2, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Jan 18, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.